Healthcare


 Eli Lilly (NASDAQ:LLY) Market Reaction Mirrors S&P 500 Futures Movement

Eli Lilly (NASDAQ:LLY) Market Reaction Mirrors S&P 500 Futures Movement

February 18, 2026 12:00 AM PST| By Anmol Khazanchi

Eli Lilly (NYSE:LLY) advances on strong margins and institutional accumulation, with performance increasingly aligned to movements in S&P 500 futures positioning.

 Medtronic (NYSE:MDT) Balance Sheet Discipline Underscored In S&P 500 Index

Medtronic (NYSE:MDT) Balance Sheet Discipline Underscored In S&P 500 Index

February 18, 2026 12:00 AM PST| By Anmol Khazanchi

Medtronic (NYSE:MDT) remains a steady large-cap healthcare name in the S&P 500 index, supported by diversified devices, solid margins, and sustained institutional participation.

 Abbott (NYSE:ABT) Diagnostics Strength Supports Russell 1000 ETF Narrative

Abbott (NYSE:ABT) Diagnostics Strength Supports Russell 1000 ETF Narrative

February 18, 2026 12:00 AM PST| By Anmol Khazanchi

Abbott (NYSE:ABT) maintains valuation stability in the Russell 1000 ETF, backed by diversified healthcare segments, recurring demand, and institutional support.

 Cogent Biosciences (NASDAQ:COGT) Progress Versus Market Expectations This Quarter

Cogent Biosciences (NASDAQ:COGT) Progress Versus Market Expectations This Quarter

February 17, 2026 04:57 PM PST| By Anmol Khazanchi

Cogent Biosciences operates in the Canadian-relevant life sciences landscape as a clinical-stage biopharmaceutical participant within the healthcare sector. The company’s work centres on discovering and developing.

 Disc Medicine (NASDAQ:IRON) Drives Biotechnology Shifts In Views On Development Strategy

Disc Medicine (NASDAQ:IRON) Drives Biotechnology Shifts In Views On Development Strategy

February 17, 2026 04:51 PM PST| By Anmol Khazanchi

Disc Medicine operates within the clinical stage biotechnology sector, where research driven drug development is shaped by trial design, scientific validation, and regulatory checkpoints.

 How NeoGenomics (NASDAQ:NEO) Performs Amid Fluctuations In Nasdaq Today

How NeoGenomics (NASDAQ:NEO) Performs Amid Fluctuations In Nasdaq Today

February 17, 2026 12:00 AM PST| By Anmol Khazanchi

NeoGenomics (NASDAQ:NEO) stands out in Nasdaq today for its leadership in cancer diagnostics, with increasing institutional interest and a strong role in advancing personalized medicine within biotech.

 How Incyte (NASDAQ:INCY) Drives Long-Term Growth In Nasdaq Composite

How Incyte (NASDAQ:INCY) Drives Long-Term Growth In Nasdaq Composite

February 17, 2026 12:00 AM PST| By Anmol Khazanchi

Incyte (NASDAQ:INCY) stands out in the Nasdaq Composite with a focus on oncology and rare diseases. Institutional backing and strong technical trends reinforce its market position in biotechnology.

 Medtronic’s (NYSE:MDT) Debt Management Strategy Supports S&P 500 Fund Stability

Medtronic’s (NYSE:MDT) Debt Management Strategy Supports S&P 500 Fund Stability

February 17, 2026 12:00 AM PST| By Anmol Khazanchi

Medtronic (NYSE:MDT) continues to lead in the medical technology sector, supported by strong financial performance and institutional backing. As part of the S&P 500 Fund, Medtronic’s stability and consistent growth.

 Incannex Healthcare Ltd ADR (NASDAQ:IXHL) What Drove Todays Sudden Market Shift

Incannex Healthcare Ltd ADR (NASDAQ:IXHL) What Drove Todays Sudden Market Shift

February 16, 2026 04:40 PM PST| By Anmol Khazanchi

Incannex Healthcare operates in the health care and biotechnology space, where clinical-stage developers work to advance therapies through research, formulation work, and regulated testing.

 Inspire Medical Systems (NYSE:INSP) Short Interest – NYSE Composite

Inspire Medical Systems (NYSE:INSP) Short Interest – NYSE Composite

February 16, 2026 03:37 PM PST| By Anmol Khazanchi

Coverage of Inspire Medical Systems explains implantable neurostimulation technology, disclosure practices, and healthcare logistics connected to NYSE Composite representation within medical device sector operations.

 Edwards Lifesciences (NYSE:EW) Shows Institutional Concentration Trends Within The S&P 500 Today

Edwards Lifesciences (NYSE:EW) Shows Institutional Concentration Trends Within The S&P 500 Today

February 16, 2026 02:44 PM PST| By Anmol Khazanchi

Edwards Lifesciences operates within the medical technology sector, focused on healthcare equipment and device-based therapies used in areas such as structural heart care and hospital monitoring, where clinical adoption, product cycles.

 HCA Healthcare Inc (NYSE:HCA) Momentum Shines During Broad Nyse Composite Index Rally

HCA Healthcare Inc (NYSE:HCA) Momentum Shines During Broad Nyse Composite Index Rally

February 16, 2026 02:27 PM PST| By Anmol Khazanchi

Hospitals and broader healthcare services often sit at the centre of defensive demand because care needs persist across economic cycles. Within this sector, has recently drawn attention after a strong move higher over the past week.

 Keros (NASDAQ:KROS) Capital Stability Draws Nasdaq Composite Discussion

Keros (NASDAQ:KROS) Capital Stability Draws Nasdaq Composite Discussion

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

Keros Therapeutics (NASDAQ:KROS) draws attention within the Nasdaq Composite as institutional positioning and pipeline progress shape biotech valuation sensitivity.

 Regeneron (NASDAQ:REGN) Performance Challenges Broader Nasdaq Futures Volatility

Regeneron (NASDAQ:REGN) Performance Challenges Broader Nasdaq Futures Volatility

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

Regeneron (NASDAQ:REGN) delivered strong earnings while Nasdaq futures volatility frames market sentiment, with institutional participation and pipeline depth supporting valuation focus.

 WAVE (NASDAQ:WVE) Rotation Narrative Builds Beyond Nasdaq Index Tech Core

WAVE (NASDAQ:WVE) Rotation Narrative Builds Beyond Nasdaq Index Tech Core

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

WAVE Life Sciences (NASDAQ:WVE) attracts renewed focus as institutional accumulation and pipeline visibility strengthen its standing within Nasdaq index biotech comparisons.

 Repligen (NASDAQ:RGEN) Growth Sensitivity Mirrors Nasdaq Composite Moves

Repligen (NASDAQ:RGEN) Growth Sensitivity Mirrors Nasdaq Composite Moves

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

Repligen (NASDAQ:RGEN) stands out in Nasdaq Composite discussions as institutional positioning, liquidity strength, and bioprocessing demand cycles influence valuation sensitivity.

 LivaNova (NASDAQ:LIVN) Procedure Trends Intersect With Nasdaq Today Moves

LivaNova (NASDAQ:LIVN) Procedure Trends Intersect With Nasdaq Today Moves

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

LivaNova (NASDAQ:LIVN) draws focus in Nasdaq Today as institutional activity, liquidity strength, and medical device positioning influence valuation stability.

 Medtronic (NYSE:MDT) Capital Discipline Gains Focus During S&P 500 Futures

Medtronic (NYSE:MDT) Capital Discipline Gains Focus During S&P 500 Futures

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

Medtronic (NYSE:MDT) draws renewed attention as S&P 500 futures volatility frames its defensive healthcare positioning, steady margins, and strong institutional support.

 Is Merck & Co (NYSE:MRK) Strengthening After Upgrade As S&P 500 ETF Shifts

Is Merck & Co (NYSE:MRK) Strengthening After Upgrade As S&P 500 ETF Shifts

February 16, 2026 12:00 AM PST| By Anmol Khazanchi

Merck (NYSE:MRK) gains renewed focus as S&P 500 ETF allocation trends align with its oncology leadership, vaccine portfolio strength, and stable margin performance.

 Butterfly Network (NYSE:BFLY) Shares Slide After Market Momentum Fades Nyse Composite Today

Butterfly Network (NYSE:BFLY) Shares Slide After Market Momentum Fades Nyse Composite Today

February 13, 2026 01:39 PM PST| By Anmol Khazanchi

Butterfly Network operates within the medical equipment sector, a space centred on devices and tools used by clinicians for diagnosis, monitoring, and patient care across hospitals, clinics, and community settings.

Recent Articles






Investing Tips

Previous Next